Clinical Trial Equipment & Ancillary Solutions Market – By Type (Diagnostic Equipment, Laboratory Instruments, Ancillary Solutions), Service (Rental & Leasing, Supply & Logistics, Regulatory Compliance, Software), End-user – Global Forecast (2024 – 2032)

Clinical Trial Equipment & Ancillary Solutions Market Size

Clinical Trial Equipment & Ancillary Solutions Market size was valued at USD 1.5 billion in 2023 and is estimated to grow at 7.5% CAGR from 2024 to 2032. The market experienced significant momentum due to the growing complexity and globalization of clinical trials, leading to increased demand for ancillary solutions. These solutions aim to streamline procedures throughout the studies, responding to the evolving landscape of clinical research.
 

According to the data by ClinicalTrials.gov reports, as of May 17, 2023, a total (cumulative) of 452,604 registered clinical trials, with 64,838 actively recruiting participants globally. This marked a significant rise from the roughly 365,000 trials recorded in early 2021. Thus, the increasing demand due to the globalization of clinical trials has accelerated market growth significantly, paving the way for extensive market expansion in the foreseeable future.
 

Clinical trial equipment includes a wide range of devices, instruments, and tools used in the conduct of clinical trials to assess the safety and efficacy of clinical studies. This includes diagnostic equipment, laboratory instruments, and supplies tailored to specific research needs. Whereas ancillary solutions refer to supplementary services and support that facilitate various aspects of clinical trials, such as logistics, data management, regulatory compliance, and patient engagement.
 

Clinical Trial Equipment & Ancillary Solutions Market Trends

The growing focus on patient-centric trials, prioritizing patient experience and convenience via remote monitoring, decentralized trials, and virtual visits, is further driving the need for clinical trial equipment and ancillary solutions. This trend has shifted the focus toward advanced technologies and tools for clinical data management systems and analysis, thereby fostering market to meet the evolving needs of patient-centric research methods.
 

• For instance, in April 2021, CEVA Logistics introduced 'CEVA FORPATIENTS,' a new sub-brand focused on enhancing patient outcomes with comprehensive healthcare logistics solutions. It prioritizes patient-centricity by managing last-mile services for healthcare and pharmaceutical companies, meeting quality standards and study requirements. This initiative aims to broaden ancillary services supporting patient-centered studies.
   

Therefore, increasing research funding, and advancements in ancillary services along with growing adoption of clinical trial supply and logistics solutions foster the market demand for comprehensive solutions in the healthcare sector.
 

Clinical Trial Equipment & Ancillary Solutions Market Analysis

Based on type, the market is categorized into diagnostic equipment, laboratory instruments, and ancillary solutions. The diagnostic equipment segment is anticipated to reach USD 1.1 billion by 2032.
 

• Diagnostic equipment holds a dominant position in the market due to its critical role in patient assessment, disease diagnosis, and monitoring throughout clinical trials. These tools include various imaging machines, diagnostic tests, and monitoring devices essential for gathering accurate data and assessing patient health status. Thus, widespread adoption of diagnostic equipment in clinical trials is expected to spur the segmental growth.
   

Based on service, the clinical trial equipment & ancillary solutions market is classified into rental & leasing services, supply and logistics services, regulatory compliance services, and software services. The supply and logistics services segment is projected to hold the largest market share of 43.1% in 2023 and is expected to maintain dominance throughout the analysis period.
 

• As the pharmaceutical and biotechnology industries continue to expand their research and development efforts, there has been a surge in the demand for efficient and reliable supply chain solutions to support these trials. This trend is fueled by several factors, including the rising prevalence of complex and specialized therapies, globalization of clinical trials, and the imperative to expedite drug development processes. Consequently, pharmaceutical companies, contract research organizations (CROs), and other stakeholders are increasingly relying on specialized logistics providers to ensure the timely and seamless delivery of investigational drugs, medical devices, and other critical supplies to clinical trial sites worldwide. This burgeoning demand for comprehensive clinical trial supply and logistics is thus driving the market growth.
   

Based on the end-user, the clinical trial equipment & ancillary solutions market is segmented into pharmaceutical & biotechnology companies, contract research organizations (CROs), medical device companies, and other end-users. The pharmaceutical & biotechnology companies segment accounted for the largest revenue share in the market expected to account for USD 1.4 billion by 2032.
 

• The pharmaceutical & biotechnology companies drive demand for various equipment and ancillary services essential for trial conduct, including diagnostic tools, monitoring devices, and logistical solutions. Their substantial R&D investments, coupled with their extensive networks and resources, position them as dominant players shaping the market landscape.
   

U.S. dominated the North American clinical trial equipment & ancillary solutions market accounting for USD 730.7 million in 2023 and is anticipated to show significant growth over the analysis period.
 

• The pharmaceutical and biotechnology sectors in the U.S. are thriving, hosting numerous companies engaged in clinical trials worldwide. Also, the favorable regulations and substantial R&D investments foster innovation in the U.S. clinical trial equipment and ancillary services industry.
   
• Further, leading market players' presence and strategic approaches to maintain market viability have gained traction within the country. For instance, in March 2023, Almac Group's invested USD 65 million to expand supply-chain services for clinical trials in Montgomery County, Pennsylvania, which is anticipated to further stimulate the U.S. market growth.
   

Germany exhibited a high growth potential in the European clinical trial equipment & ancillary solutions market.
 

• Germany holds a prominent position in the European market, supported by its advanced healthcare infrastructure and strong pharmaceutical sector. The country is known for its high-quality medical research institutions and clinical trial sites, attracting multinational pharmaceutical companies and CROs. Therefore, usage of different ancillary solutions will augment the country level market growth.
   

The Asia Pacific clinical trial equipment & ancillary solutions market is poised for rapid growth with a CAGR of 8.0% during the forecast period.
 

• The region's burgeoning pharmaceutical industry, increasing clinical trial activities, and supportive regulatory environment contribute to this trend. For instance, according to research, the Asia-Pacific accounted for the highest proportion of early-stage phase I trials at 28%. The majority of APAC trials were in phase II (39.3%). Thus, the increasing number of trial activities anticipates to a surge in the demand for clinical equipment and ancillary solutions to meet process requirements, driving market growth in the coming years.
   
• Additionally, advancements in healthcare infrastructure and rising R&D funding further bolster market expansion in the Asia Pacific region.
   

India gained traction in the clinical trial equipment & ancillary solutions market anticipating substantial growth during the analysis period.
 

• India is an emerging market for clinical trials, driven by its large patient population, cost-effective healthcare services, and skilled workforce, thereby attracting domestic and international pharmaceutical companies. Further, rapidly growing healthcare market and supportive government policies are driving the expansion of clinical trial activities and demand for related equipment and solutions in the country.
   

Clinical Trial Equipment & Ancillary Solutions Market Share

The market for clinical trial equipment and ancillary solutions is highly competitive, with key players vying for market share through innovation and strategic partnerships. The major companies are prioritizing comprehensive supply chain and logistics services, while startups and niche companies are enhancing competitiveness with specialized ancillary solutions and technologies, shaping a dynamic market landscape.
 

Clinical Trial Equipment & Ancillary Solutions Market Companies

Some of the prominent players operating in the clinical trial equipment & ancillary solutions industry include:

• Andwin Scientific
• Ancillare, LP. 
• AXELERIST FINANCIAL
• Biocair
• ICON plc
• Imperial CRS, LLC. 
• Marken
• MESM UK.
• Myonex
• NUVISAN
• Oximio 
• Parexel International (MA) Corporation
• Quipment SAS
• Thermo Fisher Scientific Inc.
   

Clinical Trial Equipment & Ancillary Solutions Industry News:

• In February 2024, FedEx Express inaugurated the FedEx Life Science Center (LSC) in Mumbai, India, catering to clinical trial storage and logistics needs for healthcare clients in India. This center supplements FedEx's existing LSCs in Japan, South Korea, Singapore, the USA, and the Netherlands, forming a global network of storage and distribution hubs for healthcare and pharmaceutical sectors. This strategy is expected to enhance their geographic presence and expand their services in healthcare sector.
   
• In March 2022, Vibrent Health introduced an integrated platform for ancillary studies in large-cohort digital health research. This suite streamlines the adoption of third-party health research technologies, enabling users to expedite their research efforts. This cutting-edge solution aimed to enhance the efficiency of the research process, thereby strengthening its business portfolio.
   

The clinical trial equipment & ancillary solutions market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Diagnostic equipment
• Laboratory instruments
• Ancillary solutions

Market, By Service

• Rental & leasing services
• Supply and logistics services
• Regulatory compliance services
• Software services

Market, By End-user

• Pharmaceutical & biotechnology companies
• Contract research organizations (CROs)
• Medical device companies
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • The Netherlands
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa